Abstract
Percutaneous treatment of coronary bifurcation lesions remains a challenge, even with all advances in technique and materials available, such as hydrophilic guidewires, lower profile balloons and drug-eluting stents with new materials, thinner struts and less thrombogenic polymers. Despite these advances, little progress has been made in dedicated bifurcation stenting. The degree of technical difficulty and the lack of dedicated material result in higher rates of restenosis and stent thrombosis, especially in true bifurcation lesions, in which the therapeutic strategy [...]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
